Compound 7p

Compound 7P

Compound 7P is a synthetic small molecule belonging to the arylsulfonamide-acetamide chemical class. In neurochemical and regenerative biology literature, it is catalogued as a phenotypic screening hit with no confirmed molecular target.

Because the designation "Compound 7P" is a generic project or series label rather than a unique chemical name, it has occasionally been applied to completely unrelated structures across separate pharmacological studies (such as a distinct pyranone-carbamate cholinesterase inhibitor described in 2024 literature). To maintain absolute experimental validity and ensure matrix reproducibility, this reference material is audited and verified strictly by its definitive registry identifier: CAS 1890208-58-8.

An Important Analytical Distinction: When evaluating this molecule, investigators must anchor their criteria to the specific molecular architecture shown above. This structure consists of a core acetamide bridge linking a 4-methoxypyridin-3-yl group to a heavily substituted p-toluenesulfonamide center bearing an ortho-methoxyphenyl ring. Sourcing material based purely on the text label "7P" introduces substantial experimental risk; every lot supplied by Kimera Chems is explicitly validated against a certified reference standard matching this exact structural fingerprint.

Physical & Handling Properties

Research Applications & Phenotypic Profile

In cellular modeling, Compound 7P is classified as a phenotypic screening hit. Rather than being reverse-engineered to target a pre-selected enzyme or surface receptor, the molecule was identified by observing its macro-effects on living cell assays.

Primary areas of preclinical and in vitro laboratory investigation include:

• Neurite Outgrowth Dynamics: Used in primary neuronal culture assays as a phenotypic reference compound, with neurite length and branching measured by imaging.

• Phenotypic Panel Benchmarking: Serving as a structural comparator in high-throughput neuroregeneration screening panels to catalog the functional differences of varying multi-substituted arylsulfonamide frameworks.

Mechanistic Transparency Note: Because Compound 7P was discovered through outward phenotypic responses, its precise upstream molecular target has not yet been definitively mapped. Kimera Chems intentionally details only verified, data-backed literature profiles. Speculative mechanisms occasionally found elsewhere (such as unverified direct thromboxane or primary mitochondrial pathway claims) lack traceable primary source verification and should be treated with appropriate scientific skepticism.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

• PE-22-28
• Cerebrolysin
• Emoxypine Succinate
• J-147

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.